login
Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

St Jude Medical establishes Cardiovascular Division


Thursday, 16 Nov 2006 00:00

St Jude Medical is combining its Cardiac Surgery and Cardiology divisions to create a new Cardiovascular Division, effective 1st January 2007. The Cardiovascular Division will focus on developing and bringing to market medical device technology and services to help patients who suffer from vascular disease or structural heart defects. The Cardiovascular Division will incorporate the activities currently managed by the Cardiac Surgery Division and by the Cardiology Division. The company will continue to have specialised cardiac surgery and cardiology sales forces.

According to Daniel J Starks, chairman, president and CEO of St Jude Medical, the company's cardiology and cardiac surgery businesses will be stronger together than each business is separately. Moreover, he claimed that by streamlining the organisation, the company can boost operating efficiencies and ultimately use the associated savings to invest in research and development.

The new Cardiovascular Division will be led by George J Fazio, who has served as president of St Jude Medical's Cardiac Surgery Division since 2004. Prior to his current role, Fazio was appointed president of St Jude Medical Europe in 2001. His preceding roles included president, Health Care Services for St Jude Medical, and general manager for St Jude Medical's operations in Canada.

Paul R Buckman, currently president of St Jude Medical's Cardiology Division, will become corporate vice president of Business Development. Since joining St Jude Medical in 2004 in his current role, Buckman has overseen a significant expansion of the Cardiology Division's products and programmes. The company is also initiating several changes to enhance the efficiency and effectiveness of its sales and customer service operations in certain international geographies.

As a result of these restructuring plans, St Jude Medical expects to incur a pre-tax charge of US$25 million to US$35 million during the third quarter of 2006. "The creation of a new Cardiovascular Division, together with the expansion of our sales force and recent new product introductions, are part of our comprehensive program to position St Jude Medical to deliver a minimum 15% growth in 2007 and beyond," Starks concluded.



Most popular


Vascular Dynamics’ MobiusHD system receives CE mark for the treatment of resistant hypertension
Wednesday, 06 Jan 2016
The MobiusHD minimally invasive system from Vascular Dynamics has been granted CE mark approval for the treatment of resistant hypertension. Vascular Dynamics’ MobiusHD system receives CE mark for the treatment of resistant hypertension

US Medicare to cover Boston Scientific Watchman left atrial appendage closure device
Tuesday, 09 Feb 2016
The US Centers for Medicare and Medicaid Services (CMS) are to cover percutaneous left atrial appendage closure (LAAC) therapy under specific criteria, as outlined in the agency’s final National C... US Medicare to cover Boston Scientific Watchman left atrial appendage closure device

Orsiro may provide benefit over Xience for STEMI patients
Thursday, 07 Jan 2016
A pre-specified substudy of BIOSCIENCE, published in EuroIntervention, has found that Orsiro is associated with a significantly lower rate of target lesion failure than is Xience in STEMI patients at ... Orsiro may provide benefit over Xience for STEMI patients

Features


Building the ideal heart team for transcatheter mitral valve interventions
Monday, 08 Feb 2016
In this commentary, Vinayak Bapat outlines transcatheter mitral valve interventions and reviews which specialists should comprise the optimal heart team for such procedures. Building the ideal heart team for transcatheter mitral valve interventions

Training is the key to wider adoption of the transradial approach for PCI in the USA
Monday, 25 Jan 2016
This commentary explores why the USA, despite the data supporting the transradial approach, has been more reluctant than other countries to adopt the approach. Training is the key to wider adoption of the transradial approach for PCI in the USA

Profiles


Corrado Tamburino
Tuesday, 20 Oct 2015
Corrado Tamburino (full professor of Cardiology, Ferrarotto & Policlinico Hospitals, University of C... Corrado Tamburino

Javier Escaned
Wednesday, 02 Sep 2015
Javier Escaned (head of Section, Interventional Cardiology Unit, Hospital Clinico San Carlos, M... Javier Escaned

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions